Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Isavuconazole Kinetic Exploration for Clinical Practice.
Darnaud L, Lamoureux F, Godet C, Pontier S, Debard A, Venisse N, Martins P, Concordet D, Gandia P. Darnaud L, et al. Among authors: venisse n. Drugs R D. 2018 Dec;18(4):317-321. doi: 10.1007/s40268-018-0251-y. Drugs R D. 2018. PMID: 30306415 Free PMC article.
[Level of evidence for therapeutic drug monitoring of aminoglycosides].
Venisse N, Boulamery A; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Venisse N, et al. Therapie. 2011 Jan-Feb;66(1):39-44. doi: 10.2515/therapie/2011001. Epub 2011 Apr 7. Therapie. 2011. PMID: 21466776 Review. French.
Niveau de preuve du suivi thérapeutique pharmacologique de la teicoplanine.
Boulamery A, Venisse N, Le Guellec C; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Boulamery A, et al. Among authors: venisse n. Therapie. 2011 Jan-Feb;66(1):45-50. doi: 10.2515/therapie/2011003. Therapie. 2011. PMID: 27393464 French.
Niveau de preuve du suivi thérapeutique pharmacologique des aminosides.
Venisse N, Boulamery A; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Venisse N, et al. Therapie. 2011 Jan-Feb;66(1):39-44. doi: 10.2515/therapie/2011001. Therapie. 2011. PMID: 27393463 French.
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Venisse N, Peytavin G, Bouchet S, Gagnieu MC, Garraffo R, Guilhaumou R, Solas C; ANRS-AC43 Clinical Pharmacology Committee, SFPT Therapeutic Drug Monitoring and Treatment Personalization group. Venisse N, et al. Antiviral Res. 2020 Sep;181:104866. doi: 10.1016/j.antiviral.2020.104866. Epub 2020 Jul 10. Antiviral Res. 2020. PMID: 32659293 Free PMC article. Review.
Preparation and stability of voriconazole eye drop solution.
Dupuis A, Tournier N, Le Moal G, Venisse N. Dupuis A, et al. Among authors: venisse n. Antimicrob Agents Chemother. 2009 Feb;53(2):798-9. doi: 10.1128/AAC.01126-08. Epub 2008 Nov 10. Antimicrob Agents Chemother. 2009. PMID: 19001119 Free PMC article.
[Level of evidence for therapeutic drug monitoring of teicoplatin].
Boulamery A, Venisse N, Le Guellec C; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Boulamery A, et al. Among authors: venisse n. Therapie. 2011 Jan-Feb;66(1):45-50. doi: 10.2515/therapie/2011003. Epub 2011 Apr 7. Therapie. 2011. PMID: 21466777 Review. French.
61 results